https://www.jci.org/articles/view/74035
JCI - Predicting time to ovarian carcinoma recurrence using protein markers
time toovarian carcinomajcipredictingrecurrence
https://www.doccheck.com/en/detail/photos/6392-ascites-ovarian-carcinoma-sonography
Ascites, ovarian carcinoma, sonography - DocCheck
Malignant ascites in large ovarian carcinoma.
ovarian carcinomaascitessonographydoccheck
https://www.spandidos-publications.com/10.3892/ol.2015.3610?text=fulltext
Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
ovarian carcinomascreeningpotentialbiomarkers
https://www.siemens-healthineers.com/en-my/molecular-imaging/mi-clinical-corner/clinical-case-studies/ovarian-carcinoma
18F-FDG delineation of peritoneal carcinomatosis in ovarian carcinoma - Siemens Healthineers...
This case demonstrates a 5-minute, low-dose, whole-body, single-bed 18F-FDG delineation of peritoneal carcinomatosis in ovarian carcinoma.
18f fdgperitoneal carcinomatosisdelineation
https://www.siemens-healthineers.com/sk/molecular-imaging/mi-clinical-corner/clinical-case-studies/ovarian-carcinoma
18F-FDG delineation of peritoneal carcinomatosis in ovarian carcinoma - Siemens Healthineers...
This case demonstrates a 5-minute, low-dose, whole-body, single-bed 18F-FDG delineation of peritoneal carcinomatosis in ovarian carcinoma.
18f fdgperitoneal carcinomatosisdelineation
https://pmc.ncbi.nlm.nih.gov/articles/PMC12108836/
Mucinous Ovarian Carcinoma: Integrating Molecular Stratification into Surgical and Therapeutic...
Background/Objectives: Mucinous ovarian carcinoma (MOC) is a rare and biologically distinct subtype of epithelial ovarian cancer, typically presenting at an...
ovarian carcinomamucinousintegratingmolecularstratification
https://elifesciences.org/articles/83867
High-grade serous ovarian carcinoma organoids as models of chromosomal instability | eLife
Fifteen continuous high-grade serous ovarian carcinoma patient-derived organoids are characterized by transcriptomic, genomic, and drug sensitivity assays to...
high gradeovarian carcinoma
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-07922&r=1
Dostarlimab and LB-100 for the Treatment of Patients with Recurrent Ovarian Clear Cell Carcinoma,...
Dostarlimab and LB-100 for the Treatment of Patients with Recurrent Ovarian Clear Cell Carcinoma, Peritoneal, or Fallopian Tube Cancer
https://www.spandidos-publications.com/10.3892/ijo.2018.4360?text=fulltext
Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade...
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
high grade serous carcinoma
https://pmc.ncbi.nlm.nih.gov/articles/PMC4470044/
Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell...
Ovarian carcinoma is the leading cause of death from gynecological cancer because there is risk of chemoresistance. As previously demonstrated in our...
https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.952379/full
Frontiers | Review the progression of ovarian clear cell carcinoma from the perspective of genomics...
Ovarian clear cell carcinoma (OCCC) is a rare subtype of epithelial ovarian cancer with unique molecular characteristics, specific biological and clinical be...
ovarian clear cell carcinomathe progression
https://www.scirp.org/journal/paperinformation?paperid=40075
Granulocyte-colony stimulating factor-producing squamous cell carcinoma arising in ovarian mature...
Discover the aggressive nature of G-CSF-producing squamous cell carcinoma arising in ovarian mature cystic teratoma. Explore its clinical features and...
colony stimulating factorsquamous cell carcinoma
https://www.wikidata.org/wiki/Q70866887
Karyotypic analysis of human ovarian carcinoma cells cloned in short term agar culture - Wikidata
scientific article published on 01 June 1981
https://www.news-medical.net/news/20150330/CASI-receives-CFDA-approval-for-ENMD-2076-Phase-2-clinical-trial-in-ovarian-clear-cell-carcinoma.aspx
CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma
Jun 20, 2019 - CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing...
https://pmc.ncbi.nlm.nih.gov/articles/PMC3840218/
Sialoglycoproteins and N-Glycans from Secreted Exosomes of Ovarian Carcinoma Cells - PMC
Exosomes consist of vesicles that are secreted by several human cells, including tumor cells and neurons, and they are found in several biological fluids....
https://www.hmpgloballearningnetwork.com/site/onc/news/lb-100-plus-dostarlimab-shows-clinical-promise-platinum-resistant-ovarian-clear-cell
LB-100 Plus Dostarlimab Shows Clinical Promise in Platinum-Resistant Ovarian Clear Cell Carcinoma
Results from an ongoing, phase 1b/2 trial demonstrate that the addition of the PP2A inhibitor LB-100 to dostarlimab shows encouraging clinical efficacy with...
https://www.mdpi.com/2072-6694/13/4/906
The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
Claudin-low cancer (CL) represents a rare and biologically aggressive variant of epithelial tumor. Here, we identified a claudin-low molecular profile of...
https://www.elsevier.es/es-revista-clinica-e-investigacion-ginecologia-obstetricia-7-articulo-invasive-ovarian-seromucinous-carcinoma-developed-S0210573X21000095
Invasive ovarian seromucinous carcinoma developed on an endometrioma. The determining role of...
Endometriosis is a chronic inflammatory disease that has been associated with an increased risk of
https://pmc.ncbi.nlm.nih.gov/articles/PMC4632203/
Ovarian Clear Cell Carcinoma, Outcomes by Stage: The MSK Experience - PMC
Ovarian clear cell carcinomas (OCCC) are rare, and uncertainty exists as to the optimal treatment paradigm and validity of the FIGO staging system, especially...
ovarian clear cell carcinomaby stageoutcomes
https://www.sciencedaily.com/releases/2008/03/080310155228.htm
Recurrent Low-grade Carcinoma Of The Ovary Less Responsive To Chemo Than More Common Ovarian...
Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common...
https://www.mdpi.com/1422-0067/22/11/5869
CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
Background: Ovarian clear cell carcinoma (OCCC) is resistant to platinum chemotherapy and is characterized by poor prognosis. Today, the use of poly...